Metabolomic analysis sheds light on gut microbes’ role in cardiovascular disease risk

FHS
May 14, 2024
9:00 am

The effect of gut bacteria on non-high-density lipoprotein cholesterol (non-HDL-c) variations.

How body shape influences colorectal cancer risk

Study reveals that specific body shape phenotypes, such as general obesity and central obesity, significantly increase the risk of colorectal cancer, suggesting distinct molecular pathways

April 26, 2024

Study highlights glycolysis as a potential therapeutic target to combat Mycobacterium tuberculosis

It has been uncertain how Mycobacterium tuberculosis deflects the immune response in humans, though evidence has pointed to host immunometabolism -; the intrinsic link between

November 21, 2023

Two genomics powerhouses team up to expand infectious disease surveillance

LONDON — Two research centers that have been at the forefront of following the evolution of the SARS-CoV-2 coronavirus — one in the U.K. and

January 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.